Skip to main navigation Skip to search Skip to main content

Can a 4-Month Tolerability Assessment With Paliperidone Palmitate 1-Monthly Prevent Neuroleptic Malignant Syndrome Associated With the 3-Monthly? Analysis Based on a Spontaneous Reporting System Database in Japan

  • Fuminari Misawa
  • , Yasuo Fujii
  • , Hiroyoshi Takeuchi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)206-207
Number of pages2
JournalJournal of clinical psychopharmacology
Volume41
Issue number2
DOIs
Publication statusPublished - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this